This study is testing a drug called **alirocumab** to see if it's safe and works well for adults with **hypercholesterolemia**, which means high cholesterol levels in the blood. Alirocumab is already approved in the U.S. for treating this condition. The study will check what side effects might happen when taking the drug once a week and how much of the drug is in the blood at different times.
- Length: Participants will need to take the drug weekly for the duration of the study.
- Eligibility: Must have high LDL-C (bad cholesterol) and not be using other similar medications.
- Risks: Possible side effects from the drug; details are studied during the trial.
Before joining, make sure you understand the study's requirements, such as not changing your cholesterol medication during the trial. Your participation could help find better ways to manage high cholesterol.
How understandable was the trial content above?
Hard to understand
Easy to understand